Compounds > 2-(2-thenyl)sulfonyl-5-bromopyrimidine
Page last updated: 2024-12-07
2-(2-thenyl)sulfonyl-5-bromopyrimidine
Description
2-(2-Thenyl)sulfonyl-5-bromopyrimidine is a chemical compound with the molecular formula C9H7BrN2O2S. It is a derivative of pyrimidine, a heterocyclic aromatic compound found in many biological systems, including DNA and RNA.
Here's a breakdown of its structure and why it is important for research:
**Structure:**
* **Pyrimidine core:** The molecule is based on a pyrimidine ring, a six-membered ring containing two nitrogen atoms.
* **Thiophene ring:** It has a thiophene ring (C4H4S) attached to the pyrimidine ring via a methylene bridge (-CH2-).
* **Sulfonyl group:** A sulfonyl group (-SO2-) is attached to the thiophene ring.
* **Bromine substituent:** A bromine atom is attached to the pyrimidine ring at the 5-position.
**Importance for Research:**
This specific compound is of interest to researchers for several potential applications:
* **Pharmaceutical Research:**
* **Anti-cancer activity:** Some pyrimidine derivatives, including those with sulfonyl groups, have shown potential as anticancer agents. The bromine substitution might influence its activity.
* **Anti-inflammatory activity:** Some thiophene derivatives have shown anti-inflammatory properties. This compound might exhibit similar activity.
* **Organic Chemistry:**
* **New synthetic methods:** The compound could serve as a starting material for the synthesis of other complex organic molecules.
* **Mechanistic studies:** Its reactivity and properties can be studied to gain a better understanding of chemical transformations.
* **Materials Science:**
* **Photoluminescence:** Some thiophene-containing molecules exhibit interesting photoluminescent properties, potentially useful in organic light-emitting diodes (OLEDs).
* **Conductivity:** The sulfonyl group and the aromatic rings could influence the conductivity of the compound, making it potentially relevant for electronic applications.
**Overall:** 2-(2-Thenyl)sulfonyl-5-bromopyrimidine is a relatively new molecule with a unique combination of structural features. Its potential as a lead compound in drug discovery, a synthetic reagent, or a functional material is currently under investigation.
**Important Note:** Research on this specific compound is likely in its early stages. It's essential to consult peer-reviewed scientific publications or specialist databases for the latest findings and to avoid making assumptions about its exact biological or chemical properties without solid research evidence.
2-(2-thenyl)sulfonyl-5-bromopyrimidine: induces cell cycle specific inhibition in metaphase; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 100747 |
SCHEMBL ID | 10973380 |
MeSH ID | M0147092 |
Synonyms (15)
Synonym |
pyrimidine, 5-bromo-2-((2-thienylmethyl)sulfonyl)- |
ny 4137 |
5-bromo-2-((2-thienylmethyl)sulfonyl)pyrimidine |
nsc 360490 |
2-(2-thenyl)sulfonyl-5-bromopyrimidine |
nsc-360490 |
79685-33-9 |
nsc360490 |
5-bromo-2-(thiophen-2-ylmethylsulfonyl)pyrimidine |
ny-4137 |
DTXSID00229830 |
SCHEMBL10973380 |
E5FVW29N9W |
5-bromo-2-[(2-thienylmethyl)sulfonyl]pyrimidine |
pyrimidine, 5-bromo-2-[(2-thienylmethyl)sulfonyl]- |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.60 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.39 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |